Vaccine Therapy With High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma
Clinical trial NCT00003568 · COMPLETED
Trial details
- NCT number
- NCT00003568
- Sponsor
- University of Illinois at Chicago
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1998-11-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.